1083-P: Interim Success of an Online CME Curriculum at Overcoming Clinical Inertia to Improve Intensification of T2D

Résumé fourni par la source

Introduction and Objective: The study examined if a series of active-learning, online continuing medical education (CME) activities could improve intensification of T2D treatment by PCPs and primary care-focused NPs and PAs. Methods: Claims data (from Medscape licensed claims that represent 220 million patients’ claims) were used to assess practice. A retrospective, case-matched control design was used, requiring HCP learners to participate in at least one of the activities from October 2023-June 2024, and see at least 2 patients with T2D and prescribe 2 metformin prescriptions in the previous 6 months. CME group were matched with nonparticipating HCPs by specialty, profession, zip code, and volume of patients/prescriptions. Educational intervention included 3 active-learning, online CME activities launched between October 2023 and January 2024- a self-assessment, a call-to-action on treatment intensification, and an interactive patient simulation. Data was collected through December 2024. Results: 3,829 HCPs were included, representing 138,535 patients with T2D seen in 3 months after CME participation. Key clinical and practice characteristics of HCPs were similar for learners and control group. Compared to the control group, CME group demonstrated: 8% more patients with uncontrolled T2D with treatment intensification (P <.05); 9% more patients with T2D with weight loss plans (P <.001); and 47% relative reduction in time to treatment intensification (P =.051)​. Percent of learners who prescribed newer T2D treatments increased from 58% to 70% after education. Practice changers were more likely to have higher confidence in applying guideline recommendations and endorse a <7% A1c goal​. Conclusion: This interim analysis demonstrates the immediate (3 month) success of active-learning, online CME on improving T2D intensification in practice. Impact of education on longer-term clinical practice will be assessed with follow-up analysis in 2025. Disclosure A. Larkin: None. A. Le: None. K.S. Lucero: None. Funding Independent educational grant from Lilly

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.